Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of alogliptin 25 mg film-coated tablet under fasting conditions in healthy volunteers
TCTR20200227002Completed
- Sponsor
- Unison Laboratories
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of alogliptin (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 1 more. Started Jun 2020; status: completed.
02
Drugs
alogliptin
Beyond the preview
Go deeper on TCTR20200227002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200227002.